A detailed history of Avidity Partners Management LP transactions in Zoetis Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 71,000 shares of ZTS stock, worth $11.7 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
71,000
Holding current value
$11.7 Million
% of portfolio
0.85%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $12.3 Million - $14 Million
71,000 New
71,000 $13.9 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $3.35 Million - $4.42 Million
-22,100 Reduced 8.43%
240,000 $47.4 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $7.54 Million - $8.69 Million
45,100 Added 20.78%
262,100 $45.6 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $30.7 Million - $35.5 Million
-190,500 Reduced 46.75%
217,000 $37.4 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $59.3 Million - $71.3 Million
407,500 New
407,500 $67.8 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.